AQUACEL® Ag+ Dressings
View Large

AQUACEL® Ag+ Dressings

AQUACEL® Ag+ dressings are antimicrobial primary dressings for use in wounds that are infected or at risk of infection. They are  designed to manage the 3 key local barriers to healing - exudate, infection and biofilm. AQUACEL® Ag+ dressings incorporate proven Hydrofiber™ Technology and Ag+ Technology - a unique ionic silver-containing, antibiofilm formulation.1 AQUACEL® Ag+ dressings are available as AQUACEL® Ag+ Extra™ and AQUACEL® Ag+ Ribbon dressings.

AQUACEL® Ag+ Extra™ dressing is comprised of 2 layers of Hydrofiber™ Technology stitch bonded together making it 9x stronger and 50% more absorbent than standard AQUACEL® Ag dressing.2*

AQUACEL® Ag+ Ribbon dressing is also strengthened with stitchbonding.

*As demonstrated in-vitro

  • Ordering Information
  • Product Features
  • Additional Resources
Code
413566
PIP Code
386-2703
NHS Code
ELY514
Description
AQUACEL® Ag+ Extra™ Dressing
Size
5x5cm (2" x 2")
Quantity
10 per box
Code
413567
PIP Code
386-2695
NHS Code
ELY515
Description
AQUACEL® Ag+ Extra™ Dressing
Size
10x10cm (4" x 4")
Quantity
10 per box
Code
413568
PIP Code
386-2711
NHS Code
ELY516
Description
AQUACEL® Ag+ Extra™ Dressing
Size
15x15cm (6" x 6")
Quantity
5 per box
Code
413569
PIP Code
386-2679
NHS Code
ELY517
Description
AQUACEL® Ag+ Extra™ Dressing
Size
20x30cm (8" x 12")
Quantity
5 per box
Code
413581
PIP Code
386-0350
NHS Code
ELY520
Description
AQUACEL® Ag+ Extra™ Dressing
Size
4x10cm (1½" x 4")
Quantity
10 per box

AQUACEL® Ag+ dressings comprise two powerful technologies working synergistically to manage the key local barriers to wound healing - exudate, infection and biofilm.

Ag+ Technology  is a unique ionic silver-containing, antibiofilm formulation that:*1

  • Disrupts and beaks down biofilm slime ro expose bateria3-5
  • Kills a broad spectrum of bacteria, including antibiotic resistant superbugs, with its reservoir of silver *4,5,6
  • prevents biofilm formation*4,5

Hydrofiber™ Technology helps create an ideal environment for healing – and for Ag+ Technology to work.

  • Locks in excess exudate, bacteria and biofilm to help minimise cross infection and prevent maceration*7-12
  • Micro contours to the wound bed, maintaining optimal moisture balance and eliminating dead spaces where bacteria and biofilm can grow*13-15
  • responds to wound conditions by forming a cohesive gel, while helping to minimise pain associated with dressing changes*16-18

AQUACEL® Ag+ Extra™ dressing my be used for the management of:

  • wounds as a barrier to bacterial penetration of the dressing as this may help reduce infection;

  • wounds where there is an infection or an increased risk of infection (Extra™ only);
  • diabetic foot ulcers, leg ulcers, (venous stasis ulcers, arterial ulcers and leg ulcers of mixed aetiology) and pressure ulcers/sores (partial & full thickness);
  • surgical wounds;
  • traumatic wounds;
  • wounds that are prone to bleeding, such as wounds that have been mechanically or surgically debrided;
  • oncology wounds with exudate, such as fungoides-cutaneous tumors, fungating carcinoma, cutaneous metastasis, Kaposi’s sarcoma, and angiosarcoma;
  • wounds where bacteria are a suspected cause of (or a factor in) chronicity /non-progression.

In addition, AQUACEL® Ag+ Ribbon dressing may be used for cavity and deep wounds including sinus, undermining and tracking wounds.

*As demonstrated in vitro

References

1. Composition comprising antimicrobial metal ions and a quaternary cationic surfactant. Scientific Background Report. WO 2012136968 A1, 2012, Data on file, ConvaTec Inc.

2 - Assessment of the in vitro Physical Properties of AQUACEL® EXTRA™, AQUACEL®Ag EXTRA™ and AQUACEL® Ag+ EXTRA™ dressings. Scientific background report. WHRIA3817 TA297, 2013, Data on File, ConvaTec Inc.

3. Physical Disruption of Biofilm by AQUACEL® Ag+ Wound Dressing. Scientific Background Report. WHRI3850 MA232, 2013, Data on file, ConvaTec Inc.

4. Antimicrobial activity and prevention of biofilm reformation by AQUACEL® Ag+ EXTRA™ dressing. Scientific Background Report. WHRI3857 MA236, 2013, Data on file, ConvaTec Inc.

5. Antimicrobial activity against CA-MRSA and prevention of biofilm reformation by AQUACEL® Ag+ EXTRA™ dressing. Scientific Background Report. WHRI3875 MA239, 2013, Data on file, ConvaTec Inc.

6. Bowler PG, Welsby S, Towers V, Booth V, Hogarth A, Rowlands V, Joseph A, et al, 2012. Multidrug-resistant organisms, wounds and topical antimicrobial protection. Int Wound J. 9: 387-396.  

7. Newman GR, Walker M, Hobot JA, Bowler PG, 2006. Visualisation of bacterial sequestration and bacterial activity within hydrating Hydrober™ wound dressings. Biomaterials; 27:1129-1139.

8. Walker M, Hobot JA, Newman GR, Bowler PG, 2003. Scanning electron microscopic examination of bacterial immobilization in a carboxymethyl cellulose (AQUACEL®) and alginate dressing. Biomaterials; 24: 883-890.

9. Bowler PG, Jones SA, Davies BJ, Coyle E, 1999. Infection control properties of some wound dressings. J. Wound Care; 8: 499-502.

10. Walker M, Bowler PG, Cochrane CA, 2007. In vitro studies to show sequestration of matrix metalloproteinases by silver-containing wound care products. Ostomy/Wound Management. 2007; 53: 18-25.

11. Walker M and Parsons D, 2010. Hydrofiber Technology: its role in exudate management. Wounds UK; 6: 31-38.

12. Parsons D, Bowler PG, Myles V, Jones SA, 2005. Silver antimicrobial dressings in wound management: A comparison of antibacterial, physical and chemical characteristics. WOUNDS;17: 222-232.

13. Jones SA, Bowler PG, Walker M, 2005. Antimicrobial activity of silver-containing dressings is influenced by dressing conformability with a wound surface. WOUNDS; 17: 263-270.

14. Bowler P, Jones S, Towers V, Booth R, Parsons D, Walker M, 2010. Dressing conformability and silver-containing wound dressings. Wounds UK; 6: 14-20.

15. Walker M, Jones S, Parsons D, Booth R, Cochrane C, Bowler P, 2011. Evaluation of low-adherent antimicrobial dressings. Wounds UK; 7: 32-45.

16. Barnea Y, Armir A, Leshem D, Zaretski A, Weiss J, Shafir R, et al, 2004. Clinical comparative study of Aquacel and paraffin gauze dressing for split-skin donor site treatment. Ann Plast Surg; 53: 132-136.

17. Kogan L, Moldavsky M, Szvalb S, Govrin-Yehudain J, 2004. Comparative study of Aquacel and Silverol treatment in burns. Ann Burns Fire Disasters; 17: 201-207.

18. Brunner U, Eberlein T, 2000. Experiences with hydrofibres in the moist treatment of chronic wounds, in particular of diabetic foot. VASA; 29: 253-257.

Cookies are needed for this website to work optimally. They also help us to know a little bit about how you use our website, which improves the browsing experience.  Cookies on this site are used for traffic measurement and optimisation of page content only. By continuing to browse on this website, you indicate your consent to the use of cookies.  You may block the use of cookies by following the "How to block and avoid cookies" instructions

Learn more about our Cookie policy